Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| COGNIZANT TECHNOLOGY SOLUTIONS CORPCTSH · Entity 473 | Director | August 25, 2026 | August 27, 2026 |
| LAM RESEARCH CORPLRCX · Entity 1467 | Director | November 07, 2025 | November 10, 2025 |
| MERRIMACK PHARMACEUTICALS INCMACK · Entity 95770 | Director | June 13, 2018 | June 15, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
COGNIZANT TECHNOLOGY SOLUTIONS CORP
Report date August 25, 2026 · Filed August 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 20,464.4423 |
Reported balance
After 2026-08-25 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-08-25 · Grant · Acquired 106.5353 · Balance 20,464.4423 F1: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F2: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Non-Employee Director Compensation Guidelines (the "Guidelines"), to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) the first July 1 following the date of the Reporting Person's termination of service (other than due to death or permanent disability). |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 10,166.3121 |
Reported balance
After 2026-08-25 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-08-25 · Grant · Acquired 52.9246 · Balance 10,166.3121 F1: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F3: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 4,192.8273 |
Reported balance
After 2026-08-25 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-08-25 · Grant · Acquired 21.8273 · Balance 4,192.8273 F4: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company. F5: The restricted stock units will vest fully on June 2, 2027. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company.
F2: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Non-Employee Director Compensation Guidelines (the "Guidelines"), to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) the first July 1 following the date of the Reporting Person's termination of service (other than due to death or permanent disability).
F3: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability).
F4: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company.
F5: The restricted stock units will vest fully on June 2, 2027. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability).
LAM RESEARCH CORP
Report date November 07, 2025 · Filed November 10, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,135 |
Reported balance
After 2025-11-07 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-11-07 · Grant · Acquired 1,635 · Balance 9,135 F1: The amount reported includes shares subject to unvested restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: The amount reported includes shares subject to unvested restricted stock units.
MERRIMACK PHARMACEUTICALS INC
Report date June 13, 2018 · Filed June 15, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.67 · Expires 2028-06-12 | Direct | 7,000 |
Reported balance
After 2018-06-13 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-06-13 · Grant · Acquired 7,000 · Balance 7,000 F1: This option vests as to 1/4th of the total number of shares on 9/13/18 and an additional 1/4th of the total number of shares at the end of each successive three month period thereafter until 6/13/19, provided that such option shall vest in full on the date that is one business day prior to the date of the issuer's next annual meeting of stockholders (if earlier than 6/13/19). |
Filing footnotes · ownership attribution and instrument terms
F1: This option vests as to 1/4th of the total number of shares on 9/13/18 and an additional 1/4th of the total number of shares at the end of each successive three month period thereafter until 6/13/19, provided that such option shall vest in full on the date that is one business day prior to the date of the issuer's next annual meeting of stockholders (if earlier than 6/13/19).
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Syneos Health, Inc.
Report date September 28, 2023 · Filed September 28, 2023
Section 16 reporting ended · disclosed 2023-09-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2023-09-28 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-09-28 · Disposition to issuer · Disposed 22,629 · Balance 4,863 F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of May 10, 2023 (the "Merger Agreement"), by and among Syneos Health, Inc. (the "Issuer"), Star Parent, Inc. ("Parent") and Star Merger Sub, Inc. ("Merger Sub"). On September 28, 2023, upon the closing of the merger of Merger Sub with and into the Issuer (the "Merger") contemplated by the Merger Agreement, each outstanding share of common stock of the Issuer, par value $0.01 per share, was cancelled and automatically converted into the right to receive an amount in cash equal to $43.00 (the "Merger Consideration"), without interest, and minus any applicable withholding taxes. Row 2 · 2023-09-28 · Disposition to issuer · Disposed 4,863 · Balance 0 F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of May 10, 2023 (the "Merger Agreement"), by and among Syneos Health, Inc. (the "Issuer"), Star Parent, Inc. ("Parent") and Star Merger Sub, Inc. ("Merger Sub"). On September 28, 2023, upon the closing of the merger of Merger Sub with and into the Issuer (the "Merger") contemplated by the Merger Agreement, each outstanding share of common stock of the Issuer, par value $0.01 per share, was cancelled and automatically converted into the right to receive an amount in cash equal to $43.00 (the "Merger Consideration"), without interest, and minus any applicable withholding taxes. F2: In accordance with the Merger Agreement, effective as of immediately prior to the effective time of the Merger (the "Effective Time") and as a result of the Merger each award of restricted stock units ("RSUs") and performance stock units ("PSUs") covering shares of common stock that is outstanding immediately prior to the Effective Time (other than certain specified RSU awards and PSU awards set forth in the disclosure schedules delivered in connection with the Merger Agreement (the "Specified Awards")) was cancelled and converted into a contingent right to receive an amount in cash (without interest) (a "Contingent Cash Award") equal to the product of (i) the Merger Consideration and (ii) the aggregate number of shares of common stock subject to the award (with any performance based goals with respect to the PSU awards deemed to be achieved at the "target" level of performance or based on the actual level of achievement of performance goals, F3: continued from previous footnote: in each case, as set forth in the applicable PSU award agreement). Each Contingent Cash Award will vest and become payable pursuant to the same time-vesting schedule applicable to the underlying RSU award or PSU award from which it was converted, as applicable (including any accelerated vesting terms and conditions), subject to the holder's continued employment with or service to Parent and its subsidiaries through the applicable vesting date; and each Specified Award that is outstanding immediately prior to the Effective Time was cancelled and converted into the right to receive a cash payment (without interest) equal to the product of (i) the Merger Consideration and (ii) the aggregate number of shares of common stock subject to the award, subject to claw-back if the holder's employment is terminated by the Company for "cause" or by the holder without "good reason," in either case prior to the first anniversary of the Effective Time. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of May 10, 2023 (the "Merger Agreement"), by and among Syneos Health, Inc. (the "Issuer"), Star Parent, Inc. ("Parent") and Star Merger Sub, Inc. ("Merger Sub"). On September 28, 2023, upon the closing of the merger of Merger Sub with and into the Issuer (the "Merger") contemplated by the Merger Agreement, each outstanding share of common stock of the Issuer, par value $0.01 per share, was cancelled and automatically converted into the right to receive an amount in cash equal to $43.00 (the "Merger Consideration"), without interest, and minus any applicable withholding taxes.
F2: In accordance with the Merger Agreement, effective as of immediately prior to the effective time of the Merger (the "Effective Time") and as a result of the Merger each award of restricted stock units ("RSUs") and performance stock units ("PSUs") covering shares of common stock that is outstanding immediately prior to the Effective Time (other than certain specified RSU awards and PSU awards set forth in the disclosure schedules delivered in connection with the Merger Agreement (the "Specified Awards")) was cancelled and converted into a contingent right to receive an amount in cash (without interest) (a "Contingent Cash Award") equal to the product of (i) the Merger Consideration and (ii) the aggregate number of shares of common stock subject to the award (with any performance based goals with respect to the PSU awards deemed to be achieved at the "target" level of performance or based on the actual level of achievement of performance goals,
F3: continued from previous footnote: in each case, as set forth in the applicable PSU award agreement). Each Contingent Cash Award will vest and become payable pursuant to the same time-vesting schedule applicable to the underlying RSU award or PSU award from which it was converted, as applicable (including any accelerated vesting terms and conditions), subject to the holder's continued employment with or service to Parent and its subsidiaries through the applicable vesting date; and each Specified Award that is outstanding immediately prior to the Effective Time was cancelled and converted into the right to receive a cash payment (without interest) equal to the product of (i) the Merger Consideration and (ii) the aggregate number of shares of common stock subject to the award, subject to claw-back if the holder's employment is terminated by the Company for "cause" or by the holder without "good reason," in either case prior to the first anniversary of the Effective Time.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 25, 2026 Filed Aug 27, 2026 20:11 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 21.8273 | $0.00 | $0.00 |
DisclosureSEC source: 0001645270-26-000008 · wk-form4_1787861473.xml · derivative · entry 3 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,192.8273 Underlying: Class A Common Stock · 21.8273 shares Expires not disclosed F4 · derivative.exercise_price: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company. F4 · kind: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company. F5 · derivative.exercise_date: The restricted stock units will vest fully on June 2, 2027. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). F5 · derivative.expiration_date: The restricted stock units will vest fully on June 2, 2027. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). Read SEC document |
| August 25, 2026 Filed Aug 27, 2026 20:11 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 52.9246 | $0.00 | $0.00 |
DisclosureSEC source: 0001645270-26-000008 · wk-form4_1787861473.xml · derivative · entry 2 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,166.3121 Underlying: Class A Common Stock · 52.9246 shares Expires not disclosed F1 · derivative.exercise_price: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F1 · kind: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F3 · derivative.exercise_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). F3 · derivative.expiration_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). Read SEC document |
| August 25, 2026 Filed Aug 27, 2026 20:11 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 106.5353 | $0.00 | $0.00 |
DisclosureSEC source: 0001645270-26-000008 · wk-form4_1787861473.xml · derivative · entry 1 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,464.4423 Underlying: Class A Common Stock · 106.5353 shares Expires not disclosed F1 · derivative.exercise_price: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F1 · kind: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F2 · derivative.exercise_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Non-Employee Director Compensation Guidelines (the "Guidelines"), to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) the first July 1 following the date of the Reporting Person's termination of service (other than due to death or permanent disability). F2 · derivative.expiration_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Non-Employee Director Compensation Guidelines (the "Guidelines"), to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) the first July 1 following the date of the Reporting Person's termination of service (other than due to death or permanent disability). Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:07 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 4,171 | $0.00 | $0.00 |
DisclosureSEC source: 0001645270-26-000006 · wk-form4_1780603657.xml · derivative · entry 1 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,171 Underlying: Class A Common Stock · 4,171 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of Cognizant Technology Solutions Corporation (the "Company"). F2 · derivative.exercise_date: The RSUs will vest fully on June 2, 2027. The Reporting Person has elected, pursuant to the Company's Non-Employee Director Compensation Guidelines, to defer payment of such RSUs (and corresponding dividend equivalents, if any) until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). F2 · derivative.expiration_date: The RSUs will vest fully on June 2, 2027. The Reporting Person has elected, pursuant to the Company's Non-Employee Director Compensation Guidelines, to defer payment of such RSUs (and corresponding dividend equivalents, if any) until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). Read SEC document |
| May 27, 2026 Filed May 29, 2026 20:09 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 18.0122 | $0.00 | $0.00 |
DisclosureSEC source: 0001645270-26-000004 · wk-form4_1780085342.xml · derivative · entry 3 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,919.6262 Underlying: Class A Common Stock · 18.0122 shares Expires not disclosed F4 · derivative.exercise_price: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company. F4 · kind: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company. F5 · derivative.exercise_date: The restricted stock units will vest fully on June 3, 2026. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). F5 · derivative.expiration_date: The restricted stock units will vest fully on June 3, 2026. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). Read SEC document |
| May 27, 2026 Filed May 29, 2026 20:09 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 44.3811 | $0.00 | $0.00 |
DisclosureSEC source: 0001645270-26-000004 · wk-form4_1780085342.xml · derivative · entry 2 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,193.7613 Underlying: Class A Common Stock · 44.3811 shares Expires not disclosed F1 · derivative.exercise_price: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F1 · kind: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F3 · derivative.exercise_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). F3 · derivative.expiration_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). Read SEC document |
| May 27, 2026 Filed May 29, 2026 20:09 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 125.5958 | $0.00 | $0.00 |
DisclosureSEC source: 0001645270-26-000004 · wk-form4_1780085342.xml · derivative · entry 1 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,357.907 Underlying: Class A Common Stock · 125.5958 shares Expires not disclosed F1 · derivative.exercise_price: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F1 · kind: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F2 · derivative.exercise_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Non-Employee Director Compensation Guidelines (the "Guidelines"), to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) the first July 1 following the date of the Reporting Person's termination of service (other than due to death or permanent disability). F2 · derivative.expiration_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Non-Employee Director Compensation Guidelines (the "Guidelines"), to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) the first July 1 following the date of the Reporting Person's termination of service (other than due to death or permanent disability). Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 21:14 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 14.6635 | $0.00 | $0.00 |
DisclosureSEC source: 0001645270-26-000002 · wk-form4_1772486039.xml · derivative · entry 3 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,901.614 Underlying: Class A Common Stock · 14.6635 shares Expires not disclosed F4 · derivative.exercise_price: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company. F4 · kind: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company. F5 · derivative.exercise_date: The restricted stock units will vest fully on June 3, 2026. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). F5 · derivative.expiration_date: The restricted stock units will vest fully on June 3, 2026. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 21:14 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 36.13 | $0.00 | $0.00 |
DisclosureSEC source: 0001645270-26-000002 · wk-form4_1772486039.xml · derivative · entry 2 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,149.3802 Underlying: Class A Common Stock · 36.13 shares Expires not disclosed F1 · derivative.exercise_price: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F1 · kind: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F3 · derivative.exercise_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). F3 · derivative.expiration_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 21:14 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 102.2459 | $0.00 | $0.00 |
DisclosureSEC source: 0001645270-26-000002 · wk-form4_1772486039.xml · derivative · entry 1 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,232.3112 Underlying: Class A Common Stock · 102.2459 shares Expires not disclosed F1 · derivative.exercise_price: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F1 · kind: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F2 · derivative.exercise_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Non-Employee Director Compensation Guidelines (the "Guidelines"), to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) the first July 1 following the date of the Reporting Person's termination of service (other than due to death or permanent disability). F2 · derivative.expiration_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Non-Employee Director Compensation Guidelines (the "Guidelines"), to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) the first July 1 following the date of the Reporting Person's termination of service (other than due to death or permanent disability). Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 21:13 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 11.5687 | $0.00 | $0.00 |
DisclosureSEC source: 0001645270-25-000008 · wk-form4_1764623577.xml · derivative · entry 3 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,886.9505 Underlying: Class A Common Stock · 11.5687 shares Expires not disclosed F4 · derivative.exercise_price: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company. F4 · kind: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company. F5 · derivative.exercise_date: The restricted stock units will vest fully on June 3, 2026. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). F5 · derivative.expiration_date: The restricted stock units will vest fully on June 3, 2026. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 21:13 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 28.5044 | $0.00 | $0.00 |
DisclosureSEC source: 0001645270-25-000008 · wk-form4_1764623577.xml · derivative · entry 2 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,113.2502 Underlying: Class A Common Stock · 28.5044 shares Expires not disclosed F1 · derivative.exercise_price: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F1 · kind: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F3 · derivative.exercise_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). F3 · derivative.expiration_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 21:13 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 80.6662 | $0.00 | $0.00 |
DisclosureSEC source: 0001645270-25-000008 · wk-form4_1764623577.xml · derivative · entry 1 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,130.0653 Underlying: Class A Common Stock · 80.6662 shares Expires not disclosed F1 · derivative.exercise_price: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F1 · kind: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F2 · derivative.exercise_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Non-Employee Director Compensation Guidelines (the "Guidelines"), to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) the first July 1 following the date of the Reporting Person's termination of service (other than due to death or permanent disability). F2 · derivative.expiration_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Non-Employee Director Compensation Guidelines (the "Guidelines"), to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) the first July 1 following the date of the Reporting Person's termination of service (other than due to death or permanent disability). Read SEC document |
| November 07, 2025 Filed Nov 10, 2025 18:13 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantCommon Stock | 1,635 | $0.00 | $0.00 |
DisclosureSEC source: 0001645270-25-000006 · wk-form4_1762798431.xml · nonDerivative · entry 1 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,135 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| August 26, 2025 Filed Aug 28, 2025 21:32 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 12.3818 | $0.00 | $0.00 |
DisclosureSEC source: 0001058290-25-000305 · wk-form4_1756416744.xml · derivative · entry 3 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,875.3818 Underlying: Class A Common Stock · 12.3818 shares Expires not disclosed F4 · derivative.exercise_price: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company. F4 · kind: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company. F5 · derivative.exercise_date: The restricted stock units will vest fully on June 3, 2026. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). F5 · derivative.expiration_date: The restricted stock units will vest fully on June 3, 2026. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). Read SEC document |
| August 26, 2025 Filed Aug 28, 2025 21:32 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 30.5079 | $0.00 | $0.00 |
DisclosureSEC source: 0001058290-25-000305 · wk-form4_1756416744.xml · derivative · entry 2 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,084.7458 Underlying: Class A Common Stock · 30.5079 shares Expires not disclosed F1 · derivative.exercise_price: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F1 · kind: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F3 · derivative.exercise_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). F3 · derivative.expiration_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). Read SEC document |
| August 26, 2025 Filed Aug 28, 2025 21:32 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 86.3357 | $0.00 | $0.00 |
DisclosureSEC source: 0001058290-25-000305 · wk-form4_1756416744.xml · derivative · entry 1 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,049.3991 Underlying: Class A Common Stock · 86.3357 shares Expires not disclosed F1 · derivative.exercise_price: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F1 · kind: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F2 · derivative.exercise_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Non-Employee Director Compensation Guidelines (the "Guidelines"), to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) the first July 1 following the date of the Reporting Person's termination of service (other than due to death or permanent disability). F2 · derivative.expiration_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Non-Employee Director Compensation Guidelines (the "Guidelines"), to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) the first July 1 following the date of the Reporting Person's termination of service (other than due to death or permanent disability). Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 20:47 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 2,863 | $0.00 | $0.00 |
DisclosureSEC source: 0001058290-25-000197 · wk-form4_1749156396.xml · derivative · entry 1 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,863 Underlying: Class A Common Stock · 2,863 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of Cognizant Technology Solutions Corporation (the "Company"). F2 · derivative.exercise_date: The RSUs will vest fully on June 3, 2026. The Reporting Person has elected, pursuant to the Company's Non-Employee Director Compensation Guidelines, to defer payment of such RSUs (and corresponding dividend equivalents, if any) until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). F2 · derivative.expiration_date: The RSUs will vest fully on June 3, 2026. The Reporting Person has elected, pursuant to the Company's Non-Employee Director Compensation Guidelines, to defer payment of such RSUs (and corresponding dividend equivalents, if any) until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). Read SEC document |
| May 28, 2025 Filed May 30, 2025 21:24 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 13.1158 | $0.00 | $0.00 |
DisclosureSEC source: 0001058290-25-000165 · wk-form4_1748640246.xml · derivative · entry 3 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,417.301 Underlying: Class A Common Stock · 13.1158 shares Expires not disclosed F4 · derivative.exercise_price: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company. F4 · kind: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company. F5 · derivative.exercise_date: The restricted stock units will vest fully on June 4, 2025. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). F5 · derivative.expiration_date: The restricted stock units will vest fully on June 4, 2025. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). Read SEC document |
| May 28, 2025 Filed May 30, 2025 21:24 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 13.9587 | $0.00 | $0.00 |
DisclosureSEC source: 0001058290-25-000165 · wk-form4_1748640246.xml · derivative · entry 2 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,636.9369 Underlying: Class A Common Stock · 13.9587 shares Expires not disclosed F1 · derivative.exercise_price: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F1 · kind: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F3 · derivative.exercise_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). F3 · derivative.expiration_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). Read SEC document |
| May 28, 2025 Filed May 30, 2025 21:24 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 76.6194 | $0.00 | $0.00 |
DisclosureSEC source: 0001058290-25-000165 · wk-form4_1748640246.xml · derivative · entry 1 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,963.0634 Underlying: Class A Common Stock · 76.6194 shares Expires not disclosed F1 · derivative.exercise_price: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F1 · kind: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F2 · derivative.exercise_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Non-Employee Director Compensation Guidelines (the "Guidelines"), to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) the first July 1 following the date of the Reporting Person's termination of service (other than due to death or permanent disability). F2 · derivative.expiration_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Non-Employee Director Compensation Guidelines (the "Guidelines"), to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) the first July 1 following the date of the Reporting Person's termination of service (other than due to death or permanent disability). Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:17 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 12.4946 | $0.00 | $0.00 |
DisclosureSEC source: 0001058290-25-000037 · wk-form4_1740777435.xml · derivative · entry 3 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,404.1852 Underlying: Class A Common Stock · 12.4946 shares Expires not disclosed F4 · derivative.exercise_price: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company. F4 · kind: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company. F5 · derivative.exercise_date: The restricted stock units will vest fully on June 4, 2025. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). F5 · derivative.expiration_date: The restricted stock units will vest fully on June 4, 2025. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:17 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 13.2977 | $0.00 | $0.00 |
DisclosureSEC source: 0001058290-25-000037 · wk-form4_1740777435.xml · derivative · entry 2 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,622.9782 Underlying: Class A Common Stock · 13.2977 shares Expires not disclosed F1 · derivative.exercise_price: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F1 · kind: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F3 · derivative.exercise_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). F3 · derivative.expiration_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:17 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 72.9908 | $0.00 | $0.00 |
DisclosureSEC source: 0001058290-25-000037 · wk-form4_1740777435.xml · derivative · entry 1 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,886.444 Underlying: Class A Common Stock · 72.9908 shares Expires not disclosed F1 · derivative.exercise_price: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F1 · kind: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F2 · derivative.exercise_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Non-Employee Director Compensation Guidelines (the "Guidelines"), to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) the first July 1 following the date of the Reporting Person's termination of service (other than due to death or permanent disability). F2 · derivative.expiration_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Non-Employee Director Compensation Guidelines (the "Guidelines"), to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) the first July 1 following the date of the Reporting Person's termination of service (other than due to death or permanent disability). Read SEC document |
| November 27, 2024 Filed Dec 2, 2024 21:25 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 12.5541 | $0.00 | $0.00 |
DisclosureSEC source: 0001058290-24-000355 · wk-form4_1733174715.xml · derivative · entry 3 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,391.6906 Underlying: Class A Common Stock · 12.5541 shares Expires not disclosed F4 · derivative.exercise_price: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company. F4 · kind: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company. F5 · derivative.exercise_date: The restricted stock units will vest fully on June 4, 2025. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). F5 · derivative.expiration_date: The restricted stock units will vest fully on June 4, 2025. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). Read SEC document |
| November 27, 2024 Filed Dec 2, 2024 21:25 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 13.361 | $0.00 | $0.00 |
DisclosureSEC source: 0001058290-24-000355 · wk-form4_1733174715.xml · derivative · entry 2 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,609.6805 Underlying: Class A Common Stock · 13.361 shares Expires not disclosed F1 · derivative.exercise_price: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F1 · kind: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F3 · derivative.exercise_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). F3 · derivative.expiration_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). Read SEC document |
| November 27, 2024 Filed Dec 2, 2024 21:25 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 73.3378 | $0.00 | $0.00 |
DisclosureSEC source: 0001058290-24-000355 · wk-form4_1733174715.xml · derivative · entry 1 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,813.4532 Underlying: Class A Common Stock · 73.3378 shares Expires not disclosed F1 · derivative.exercise_price: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F1 · kind: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F2 · derivative.exercise_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Non-Employee Director Compensation Guidelines (the "Guidelines"), to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) the first July 1 following the date of the Reporting Person's termination of service (other than due to death or permanent disability). F2 · derivative.expiration_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Non-Employee Director Compensation Guidelines (the "Guidelines"), to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) the first July 1 following the date of the Reporting Person's termination of service (other than due to death or permanent disability). Read SEC document |
| November 08, 2024 Filed Nov 12, 2024 16:28 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantCommon Stock | 2,950 | $0.00 | $0.00 |
DisclosureSEC source: 0000707549-24-000148 · wk-form4_1731428930.xml · nonDerivative · entry 1 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| August 28, 2024 Filed Aug 30, 2024 20:30 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 13.1365 | $0.00 | $0.00 |
DisclosureSEC source: 0001058290-24-000268 · wk-form4_1725049824.xml · derivative · entry 3 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,379.1365 Underlying: Class A Common Stock · 13.1365 shares Expires not disclosed F4 · derivative.exercise_price: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company. F4 · kind: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company. F5 · derivative.exercise_date: The restricted stock units will vest fully on June 4, 2025. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). F5 · derivative.expiration_date: The restricted stock units will vest fully on June 4, 2025. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). Read SEC document |
| August 28, 2024 Filed Aug 30, 2024 20:30 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 13.9807 | $0.00 | $0.00 |
DisclosureSEC source: 0001058290-24-000268 · wk-form4_1725049824.xml · derivative · entry 2 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,596.3195 Underlying: Class A Common Stock · 13.9807 shares Expires not disclosed F1 · derivative.exercise_price: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F1 · kind: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F3 · derivative.exercise_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). F3 · derivative.expiration_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). Read SEC document |
| August 28, 2024 Filed Aug 30, 2024 20:30 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 76.7402 | $0.00 | $0.00 |
DisclosureSEC source: 0001058290-24-000268 · wk-form4_1725049824.xml · derivative · entry 1 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,740.1154 Underlying: Class A Common Stock · 76.7402 shares Expires not disclosed F1 · derivative.exercise_price: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F1 · kind: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F2 · derivative.exercise_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Non-Employee Director Compensation Guidelines (the "Guidelines"), to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) the first July 1 following the date of the Reporting Person's termination of service (other than due to death or permanent disability). F2 · derivative.expiration_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Non-Employee Director Compensation Guidelines (the "Guidelines"), to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) the first July 1 following the date of the Reporting Person's termination of service (other than due to death or permanent disability). Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:43 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 3,366 | $0.00 | $0.00 |
DisclosureSEC source: 0001058290-24-000186 · wk-form4_1717706599.xml · derivative · entry 1 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,366 Underlying: Class A Common Stock · 3,366 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of Cognizant Technology Solutions Corporation (the "Company"). F2 · derivative.exercise_date: The RSUs will vest fully on June 4, 2025. The Reporting Person has elected, pursuant to the Company's Non-Employee Director Compensation Guidelines, to defer payment of such RSUs (and corresponding dividend equivalents, if any) until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). F2 · derivative.expiration_date: The RSUs will vest fully on June 4, 2025. The Reporting Person has elected, pursuant to the Company's Non-Employee Director Compensation Guidelines, to defer payment of such RSUs (and corresponding dividend equivalents, if any) until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). Read SEC document |
| May 29, 2024 Filed May 31, 2024 21:01 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 16.1804 | $0.00 | $0.00 |
DisclosureSEC source: 0001058290-24-000152 · wk-form4_1717189257.xml · derivative · entry 2 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,582.3388 Underlying: Class A Common Stock · 16.1804 shares Expires not disclosed F3 · derivative.exercise_price: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company. F3 · kind: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company. F4 · derivative.exercise_date: The restricted stock units will vest fully on June 6, 2024. The Reporting Person has elected, pursuant to the Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). F4 · derivative.expiration_date: The restricted stock units will vest fully on June 6, 2024. The Reporting Person has elected, pursuant to the Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). Read SEC document |
| May 29, 2024 Filed May 31, 2024 21:01 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 88.8141 | $0.00 | $0.00 |
DisclosureSEC source: 0001058290-24-000152 · wk-form4_1717189257.xml · derivative · entry 1 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,663.3752 Underlying: Class A Common Stock · 88.8141 shares Expires not disclosed F1 · derivative.exercise_price: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F1 · kind: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F2 · derivative.exercise_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Non-Employee Director Compensation Guidelines (the "Guidelines"), to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) the first July 1 following the date of the Reporting Person's termination of service (other than due to death or permanent disability). F2 · derivative.expiration_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Non-Employee Director Compensation Guidelines (the "Guidelines"), to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) the first July 1 following the date of the Reporting Person's termination of service (other than due to death or permanent disability). Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 22:49 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 13.5801 | $0.00 | $0.00 |
DisclosureSEC source: 0001058290-24-000058 · wk-form4_1709333360.xml · derivative · entry 2 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,566.1584 Underlying: Class A Common Stock · 13.5801 shares Expires not disclosed F1 · security: The Board of Directors (the "Board") of Cognizant Technology Solutions Corporation (the "Company") has determined that all dividend equivalent rights on outstanding and any future restricted stock units (including deferred stock units and restricted stock units with deferred and non-deferred settlement) granted to current and future non-employee members of the Board that relate to ordinary cash dividends with a record date on or after September 7, 2023 shall be credited in the form of additional restricted stock units that are subject to the same terms (including vesting and settlement) as the restricted stock units to which they relate. F4 · derivative.exercise_price: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company. F4 · kind: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company. F5 · derivative.exercise_date: The restricted stock units will vest fully on June 6, 2024. The Reporting Person has elected, pursuant to the Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). F5 · derivative.expiration_date: The restricted stock units will vest fully on June 6, 2024. The Reporting Person has elected, pursuant to the Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 22:49 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 74.5412 | $0.00 | $0.00 |
DisclosureSEC source: 0001058290-24-000058 · wk-form4_1709333360.xml · derivative · entry 1 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,574.5611 Underlying: Class A Common Stock · 74.5412 shares Expires not disclosed F1 · security: The Board of Directors (the "Board") of Cognizant Technology Solutions Corporation (the "Company") has determined that all dividend equivalent rights on outstanding and any future restricted stock units (including deferred stock units and restricted stock units with deferred and non-deferred settlement) granted to current and future non-employee members of the Board that relate to ordinary cash dividends with a record date on or after September 7, 2023 shall be credited in the form of additional restricted stock units that are subject to the same terms (including vesting and settlement) as the restricted stock units to which they relate. F2 · derivative.exercise_price: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F2 · kind: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F3 · derivative.exercise_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Non-Employee Director Compensation Guidelines (the "Guidelines"), to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) the first July 1 following the date of the Reporting Person's termination of service (other than due to death or permanent disability). F3 · derivative.expiration_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Non-Employee Director Compensation Guidelines (the "Guidelines"), to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) the first July 1 following the date of the Reporting Person's termination of service (other than due to death or permanent disability). Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 21:17 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 14.5783 | $0.00 | $0.00 |
DisclosureSEC source: 0001058290-23-000372 · wk-form4_1701724665.xml · derivative · entry 2 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,552.5783 Underlying: Class A Common Stock · 14.5783 shares Expires not disclosed F1 · security: The Board of Directors (the "Board") of Cognizant Technology Solutions Corporation (the "Company") has determined that all dividend equivalent rights on outstanding and any future restricted stock units (including deferred stock units and restricted stock units with deferred and non-deferred settlement) granted to current and future non-employee members of the Board that relate to ordinary cash dividends with a record date on or after September 7, 2023 shall be credited in the form of additional restricted stock units that are subject to the same terms (including vesting and settlement) as the restricted stock units to which they relate. F4 · derivative.exercise_price: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company. F4 · kind: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock of the Company. F5 · derivative.exercise_date: The restricted stock units will vest fully on June 6, 2024. The Reporting Person has elected, pursuant to the Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). F5 · derivative.expiration_date: The restricted stock units will vest fully on June 6, 2024. The Reporting Person has elected, pursuant to the Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 21:17 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 80.0199 | $0.00 | $0.00 |
DisclosureSEC source: 0001058290-23-000372 · wk-form4_1701724665.xml · derivative · entry 1 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,500.0199 Underlying: Class A Common Stock · 80.0199 shares Expires not disclosed F1 · security: The Board of Directors (the "Board") of Cognizant Technology Solutions Corporation (the "Company") has determined that all dividend equivalent rights on outstanding and any future restricted stock units (including deferred stock units and restricted stock units with deferred and non-deferred settlement) granted to current and future non-employee members of the Board that relate to ordinary cash dividends with a record date on or after September 7, 2023 shall be credited in the form of additional restricted stock units that are subject to the same terms (including vesting and settlement) as the restricted stock units to which they relate. F2 · derivative.exercise_price: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F2 · kind: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company. F3 · derivative.exercise_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Non-Employee Director Compensation Guidelines (the "Guidelines"), to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) the first July 1 following the date of the Reporting Person's termination of service (other than due to death or permanent disability). F3 · derivative.expiration_date: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Non-Employee Director Compensation Guidelines (the "Guidelines"), to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) the first July 1 following the date of the Reporting Person's termination of service (other than due to death or permanent disability). Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 21:02 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | Exercise / conversionClass A Common Stock Option (Right to Buy) · Derivative | 1,827 | $0.00 Strike: $59.52 | $0.00 |
DisclosureSEC source: 0001058290-23-000332 · wk-form4_1700082147.xml · derivative · entry 2 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 1,827 shares Expires 2024-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option was granted on April 1, 2017, pursuant to the Cognizant Technology Solutions Corporation 2009 Incentive Compensation Plan and vested in two equal annual installments on April 1, 2018, and April 1, 2019. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 21:02 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | Exercise / conversionClass A Common Stock | 1,827 | $59.52 | $108,743.04 |
DisclosureSEC source: 0001058290-23-000332 · wk-form4_1700082147.xml · nonDerivative · entry 1 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,827 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2023 Filed Nov 13, 2023 17:53 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantCommon Stock | 369 | $0.00 | $0.00 |
DisclosureSEC source: 0000707549-23-000142 · wk-form4_1699898003.xml · nonDerivative · entry 2 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 455 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| November 10, 2023 Filed Nov 13, 2023 17:53 UTC | LAM RESEARCH CORP LRCX · Entity 1467 | GrantCommon Stock | 86 | $0.00 | $0.00 |
DisclosureSEC source: 0000707549-23-000142 · wk-form4_1699898003.xml · nonDerivative · entry 1 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document |
| September 28, 2023 Filed Sep 28, 2023 17:04 UTC | Syneos Health, Inc. SYNH · Entity 109360 | Disposition to issuerClass A Common Stock | 4,863 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-050770 · doc4.xml · nonDerivative · entry 2 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of May 10, 2023 (the "Merger Agreement"), by and among Syneos Health, Inc. (the "Issuer"), Star Parent, Inc. ("Parent") and Star Merger Sub, Inc. ("Merger Sub"). On September 28, 2023, upon the closing of the merger of Merger Sub with and into the Issuer (the "Merger") contemplated by the Merger Agreement, each outstanding share of common stock of the Issuer, par value $0.01 per share, was cancelled and automatically converted into the right to receive an amount in cash equal to $43.00 (the "Merger Consideration"), without interest, and minus any applicable withholding taxes. F2 · price: In accordance with the Merger Agreement, effective as of immediately prior to the effective time of the Merger (the "Effective Time") and as a result of the Merger each award of restricted stock units ("RSUs") and performance stock units ("PSUs") covering shares of common stock that is outstanding immediately prior to the Effective Time (other than certain specified RSU awards and PSU awards set forth in the disclosure schedules delivered in connection with the Merger Agreement (the "Specified Awards")) was cancelled and converted into a contingent right to receive an amount in cash (without interest) (a "Contingent Cash Award") equal to the product of (i) the Merger Consideration and (ii) the aggregate number of shares of common stock subject to the award (with any performance based goals with respect to the PSU awards deemed to be achieved at the "target" level of performance or based on the actual level of achievement of performance goals, F3 · price: continued from previous footnote: in each case, as set forth in the applicable PSU award agreement). Each Contingent Cash Award will vest and become payable pursuant to the same time-vesting schedule applicable to the underlying RSU award or PSU award from which it was converted, as applicable (including any accelerated vesting terms and conditions), subject to the holder's continued employment with or service to Parent and its subsidiaries through the applicable vesting date; and each Specified Award that is outstanding immediately prior to the Effective Time was cancelled and converted into the right to receive a cash payment (without interest) equal to the product of (i) the Merger Consideration and (ii) the aggregate number of shares of common stock subject to the award, subject to claw-back if the holder's employment is terminated by the Company for "cause" or by the holder without "good reason," in either case prior to the first anniversary of the Effective Time. Read SEC document |
| September 28, 2023 Filed Sep 28, 2023 17:04 UTC | Syneos Health, Inc. SYNH · Entity 109360 | Disposition to issuerClass A Common Stock | 22,629 | $43.00 | $973,047.00 |
DisclosureSEC source: 0001209191-23-050770 · doc4.xml · nonDerivative · entry 1 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,863 F1 · price: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of May 10, 2023 (the "Merger Agreement"), by and among Syneos Health, Inc. (the "Issuer"), Star Parent, Inc. ("Parent") and Star Merger Sub, Inc. ("Merger Sub"). On September 28, 2023, upon the closing of the merger of Merger Sub with and into the Issuer (the "Merger") contemplated by the Merger Agreement, each outstanding share of common stock of the Issuer, par value $0.01 per share, was cancelled and automatically converted into the right to receive an amount in cash equal to $43.00 (the "Merger Consideration"), without interest, and minus any applicable withholding taxes. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:55 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 3,538 | $0.00 | $0.00 |
DisclosureSEC source: 0001058290-23-000213 · wf-form4_168625771046457.xml · derivative · entry 1 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,538 Underlying: Class A Common Stock · 3,538 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of Cognizant Technology Solutions Corporation (the "Company"). F2 · derivative.exercise_date: The RSUs will vest fully on June 6, 2024. The Reporting Person has elected, pursuant to the Company's Non-Employee Director Compensation Guidelines, to defer payment of such RSUs (and corresponding dividend equivalents, if any) until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). F2 · derivative.expiration_date: The RSUs will vest fully on June 6, 2024. The Reporting Person has elected, pursuant to the Company's Non-Employee Director Compensation Guidelines, to defer payment of such RSUs (and corresponding dividend equivalents, if any) until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) in three equal installments on July 1 in the first, second and third years following the date of the Reporting Person's termination of service (other than due to death or permanent disability). Read SEC document |
| May 25, 2023 Filed May 30, 2023 17:08 UTC | Syneos Health, Inc. SYNH · Entity 109360 | GrantClass A Common Stock | 4,863 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032930 · doc4.xml · nonDerivative · entry 1 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,492 F1 · shares: Represents an award of restricted stock units that vests in full one year from the grant date, or, if earlier, the date of the 2024 annual meeting of stockholders but only to the extent the director is not re-elected as a non-employee director at such annual meeting, in each case, subject to continued service on the Issuer's Board of Directors. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 21:31 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 2,834 | $0.00 | $0.00 |
DisclosureSEC source: 0001058290-22-000189 · wf-form4_165481027549142.xml · derivative · entry 1 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,834 Underlying: Class A Common Stock · 2,834 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of Cognizant Technology Solutions Corporation (the "Company"). F2 · derivative.exercise_date: The RSUs will vest fully on June 7, 2023. The Reporting Person has elected, pursuant to the Company's Non-Employee Director Compensation Guidelines, to defer payment of such RSUs (and corresponding dividend equivalents, if any) until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) the first July 1 following the date of the Reporting Person's termination of service (other than due to death or permanent disability). F2 · derivative.expiration_date: The RSUs will vest fully on June 7, 2023. The Reporting Person has elected, pursuant to the Company's Non-Employee Director Compensation Guidelines, to defer payment of such RSUs (and corresponding dividend equivalents, if any) until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) the first July 1 following the date of the Reporting Person's termination of service (other than due to death or permanent disability). Read SEC document |
| May 25, 2022 Filed May 27, 2022 17:04 UTC | Syneos Health, Inc. SYNH · Entity 109360 | GrantClass A Common Stock | 2,839 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-032626 · doc4.xml · nonDerivative · entry 1 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,629 F1 · shares: Represents an award of restricted stock units that vests in full one year from the grant date, or, if earlier, the date of the next subsequent annual meeting following the grant date but only to the extent the director is not re-elected as a non-employee director at such annual meeting, in each case, subject to continued service on the Issuer's Board of Directors. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 20:52 UTC | COGNIZANT TECHNOLOGY SOLUTIONS CORP CTSH · Entity 473 | GrantRestricted Stock Units · Derivative | 2,949 | $0.00 | $0.00 |
DisclosureSEC source: 0001058290-21-000129 · wf-form4_162275353238756.xml · derivative · entry 1 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,949 Underlying: Class A Common Stock · 2,949 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of Cognizant Technology Solutions Corporation (the "Company"). F2 · derivative.exercise_date: The RSUs will vest fully on June 1, 2022. F3 · derivative.exercise_date: Vested shares will be delivered to the Reporting Person upon the earliest to occur of (i) a "change in control event" of the Company, (ii) the Reporting Person's death or permanent disability or (iii) the first July 1 following the date the Reporting Person terminates service with the Company. F2 · derivative.expiration_date: The RSUs will vest fully on June 1, 2022. F3 · derivative.expiration_date: Vested shares will be delivered to the Reporting Person upon the earliest to occur of (i) a "change in control event" of the Company, (ii) the Reporting Person's death or permanent disability or (iii) the first July 1 following the date the Reporting Person terminates service with the Company. Read SEC document |
| May 12, 2021 Filed May 14, 2021 17:09 UTC | Syneos Health, Inc. SYNH · Entity 109360 | GrantClass A Common Stock | 2,364 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-032810 · doc4.xml · nonDerivative · entry 1 Dineen John M. · CIK 0001645270 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,790 F1 · shares: Represents an award of restricted stock units that vests in full one year from the grant date, or, if earlier, the date of the next subsequent annual meeting following the grant date but only to the extent the director is not re-elected as a non-employee director at such annual meeting, in each case, subject to continued service on the Issuer's Board of Directors. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.